Form 4: Macrogenics Director Jay Philip Siegel Reports Acquisition of Stock Options and Restricted Stock Units

Director Jay Philip Siegel reports acquisition of stock options and restricted stock units in Macrogenics Inc.

Summary

• On May 21, 2024, Jay Philip Siegel, a director of Macrogenics Inc. (MGNX), reported the acquisition of derivative securities.
• These acquisitions include 16,500 stock options with an exercise price of $4.26, expiring on May 21, 2034, and 6,500 restricted stock units (RSUs).
• The RSUs will vest one year after the grant date or the day before the next annual meeting, whichever is earlier.
• The stock options vest in monthly increments over 12 months from the grant date.
• Following these transactions, Siegel directly owns 16,500 stock options and 6,500 RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard disclosure of insider transactions. The acquisition of shares by a director could be seen as a positive signal, but it's not definitively bullish.

Positives

• The acquisition of stock options and RSUs by a director may signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The acquisition of stock options and RSUs by a director could positively influence shareholder sentiment.

Key Dates